NFE2L2 and prostate carcinoma: A study that analyzed the effect of Z-Ligustilide in the murine prostate cancer cell line reported that it increases NRF2 mRNA and protein expression in TRAMP C1 cells by reducing the expression of DNMTs and demethylating the DNA in the NRF2 gene promoter.